tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Pelthos Therapeutics Ord Shs

PTHS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
28.660USD
+2.580+9.83%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
92.70M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ
TradingKey ์ฐจํŠธ
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

+9.83%

5์ผ

+10.57%

1๊ฐœ์›”

+2.36%

6๊ฐœ์›”

+19.32%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

-7.55%

1๋…„

+37.43%

ํ•ต์‹ฌ ์ˆ˜์น˜
26.740์‹œ๊ฐ€
29.090์ตœ๊ณ ๊ฐ€
324.26K๊ฑฐ๋ž˜๋Ÿ‰
์†์‹คP/E TTM
์†์‹ค๋™์  P/E ๋น„์œจ
--๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
10.03%ํšŒ์ „์œจ
26.250์ „์ผ ์ข…๊ฐ€
25.920์ตœ์ €๊ฐ€
7.80M๋งค์ถœ์•ก
์†์‹ค์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
2.38P/B
0.00%๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
-70.53%ROA
54.29052์ฃผ ์ตœ๊ณ ๊ฐ€
2.14๊ฑฐ๋ž˜๋Ÿ‰ ๋น„์œจ
-7.96M์ˆœ์ด์ต
3.23M์ฃผ์‹
-22.9164์ฃผ๋‹น์ˆœ์ด์ต
--๋ฒ ํƒ€
-333.85%ROE
9.00052์ฃผ ์ตœ์ €๊ฐ€
12.08%๋ณ€๋™ ํญ
75.21%์ด ์ด์ต๋ฅ 
92.70M์‹œ๊ฐ€์ด์•ก
1.58๋ณด์ƒ/์œ„ํ—˜
5.01%์œ„ํ—˜๋ฅ 

Pelthos Therapeutics Ord Shs ๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์˜ˆ์ƒ๎˜

์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€

7 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
57.714
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+124.22%
์ƒ์Šน ์—ฌ๋ ฅ
๊ฐ•๋ ฅ ๋งค์ˆ˜
๋งค์ˆ˜
์œ ์ง€
๋งค๋„
๊ฐ•๋ ฅ ๋งค๋„

๋™์ข…์—…๊ณ„ ๋น„๊ต

160
์ด๊ณ„
6
์ค‘๊ฐ„
9
ํ‰๊ท 
ํšŒ์‚ฌ ์ด๋ฆ„
ํ‰๊ฐ€
๋ถ„์„๊ฐ€
Pelthos Therapeutics Ord Shs
PTHS
7
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32

์ง€ํ‘œ๎˜

์ง€ํ‘œ
๋งค๋„(1)
์ค‘๋ฆฝ(2)
๋งค์ˆ˜(3)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
0.160
์ค‘๋ฆฝ
RSI(14)
55.745
์ค‘๋ฆฝ
STOCH(KDJ)(9,3,3)
59.618
๋งค์ˆ˜
ATR(14)
2.333
๊ณ ๋ณ€๋™์„ฑ
CCI(14)
127.764
๋งค์ˆ˜
Williams %R
10.324
๊ณผ๋งค๋„
TRIX(12,20)
-0.034
๋งค๋„
StochRSI(14)
100.000
๋งค์ˆ˜
์ด๋™ ํ‰๊ท 
๋งค๋„(0)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(6)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
27.202
๋งค์ˆ˜
MA10
27.092
๋งค์ˆ˜
MA20
26.706
๋งค์ˆ˜
MA50
27.071
๋งค์ˆ˜
MA100
25.465
๋งค์ˆ˜
MA200
26.185
๋งค์ˆ˜

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ด ์ˆ˜์ต

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs ์ •๋ณด๎˜

์ข…๋ชฉ ์ฝ”๋“œ
ํšŒ์‚ฌ
CEO
์›น์‚ฌ์ดํŠธ

์ฃผ์ฃผ๎˜

์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Ligand Pharmaceuticals Inc
44.70%
Murchinson Ltd.
8.34%
Ikarian Capital LLC
7.62%
3I Management LLC
6.36%
Vanguard Capital Management, LLC
2.77%
๊ธฐํƒ€
30.19%

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Pelthos Therapeutics Ord Shs(PTHS)์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs(PTHS)์˜ ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 28.66์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs์˜ ์ข…๋ชฉ ๊ธฐํ˜ธ(Symbol)๋Š” ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs์˜ ์ข…๋ชฉ ์ฝ”๋“œ๋Š” PTHS์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” 54.29์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” 9.00์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs์˜ ์‹œ๊ฐ€์ด์•ก์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs์˜ ์‹œ๊ฐ€์ด์•ก์€ 92.70M์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs(PTHS)์˜ ํ˜„์žฌ ํˆฌ์ž ๋“ฑ๊ธ‰์€ ๋งค์ˆ˜, ๋ณด์œ , ๋งค๋„ ์ค‘ ์–ด๋–ค๊ฐ€์š”?

๎™Œ
์• ๋„๋ฆฌ์ŠคํŠธ๋“ค์— ๋”ฐ๋ฅด๋ฉด, Pelthos Therapeutics Ord Shs(PTHS)๋Š” ์ „๋ฐ˜์ ์ธ ํ‰๊ฐ€์—์„œ ๊ตฌ์ž…ํ•˜๋‹ค ๋“ฑ๊ธ‰์„ ๋ฐ›๊ณ  ์žˆ์œผ๋ฉฐ, ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” 57.71์ž…๋‹ˆ๋‹ค.

Pelthos Therapeutics Ord Shs(PTHS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pelthos Therapeutics Ord Shs(PTHS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ -23.04์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ